Recognition of pathogenic microorganisms by Toll-like receptors

Drugs of Today

Volumn 42, Issue SUPPL. A, 2006, Pages 99-105

  Netea, Mihai G ^a   Van Der Meer, J W M ^a   Kullberg, B J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 12; PROTEIN C FOS; TOLL LIKE RECEPTOR;

CANDIDA ALBICANS; CELL ACTIVATION; CONFERENCE PAPER; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE; LEISHMANIA MAJOR; LISTERIA MONOCYTOGENES; MICROORGANISM DETECTION; MYCOBACTERIUM AVIUM; NONHUMAN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; TOXOPLASMA GONDII; TRICHURIS; VIRUS REPLICATION;

ANIMALS; BACTERIA; HUMANS; IMMUNITY, NATURAL; MICE; PATTERN RECOGNITION, PHYSIOLOGICAL; TOLL-LIKE RECEPTORS; VIRUSES;

EID: 33645408281     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.M., Hoffmann, J.A. The dorsoventral regulatory gene cassette Spaetzle/Toll/Cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86: 973-83.
2. Rock, F.L., Hardiman, G., Timans, J.C., Kastelein, J.A., Bazan, J.F. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998, 95: 588-93.
3. Akira, S., Hemmi, H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003, 85: 85-95.
4. Takeda, K., Kaisho, T., Akira, S. Toll-like receptors. Annu Rev Immunol 2003, 21: 335-76.
5. Underhill, D.M., Ozinsky, A. Toll-like receptors: Key mediators of microbe detection. Curr Opin Immunol 2002, 14: 103-10.
6. Kopp, E., Medzhitov, R. Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 2003, 15: 396-401.
7. Takeuchi, O., Kawai, T., Muhlradt, P.F. et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001, 13: 933-40.
8. Takeuchi, O., Hoshino, K., Akira, S. TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus infection. J Immunol 2000, 165: 5392-6.
9. Suzuki, N., Suzuki, S., Duncan, G.S. et al. Severe impairment of interleukin-1 and Toll-like receptor signaling in mice lacking IRAK-4. Nature 2002, 416: 750-6.
10. Seki, E., Tsutsui, H., Tsuji, N.M. et al. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol 2002, 169: 3863-8.
11. Feng, C.G., Scanga, C.A., Colazzo-Custodio, C.M. et al. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol 2003, 171: 4758-64.
12. Bellocchio, S., Montagnoli, C., Bozza, S. et al. The contribution of Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004, 172: 3059-69.
13. Scanga, C.A., Aliberti, J., Jancovik, D. et al. MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J Immunol 2002, 168: 5997-6001.
14. de Veer, M.J., Curtis, J.M. Baldwin, T.M. et al. MyD88 is essential for clearance of Leishmania major: Possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol 2003, 33: 2822-31.
15. Helmby, H., Grencis, R.K. Essential role for TLR4 and MyD88 in the development of chronic intestinal nematode infection. Eur J Immunol 2003, 33: 2974-9.
16. Picard, C., Puel, A., Bonnet, M. et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003, 299: 2076-9.
17. Medvedev, A.E., Lentschat, A., Kuhns, D.B. et al. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med 2003, 198: 521-31.
18. Kristian, S.A., Lauth, X., Nizet, V. et al. Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J Infect Dis 2003, 188: 414-23.
19. Echchannaoui, H., Frei, K., Schnell, C., Leib, S.L., Zimmerli, W., Landmann, R. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis 2002, 186: 798-806.
20. Koedel, U., Angele, B., Rupprecht, T. et al. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J Immunol 2003, 170: 438-44.
21. Woods, J.P., Frelinger, J.A., Warrack, G., Cannon, J.G. Mouse genetic locus LPS influences susceptibility to Neisseria meningitidis infection. Infect Immun 1988, 56: 1950-5.
22. Shahin, R.D., Engberg, I., Hagberg, L., Svanborg Eden, C. Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local Gram-negative infection. J Immunol 1987, 138: 3475-80.
23. Svanborg, C., Frendeus, B., Godaly, G., Hang, L., Hedlund, M., Wachtler, C. Toll-like receptor signaling and chemokine receptor expression influence the severity of urinary tract infection. J Infect Dis 2001, 183(Suppl. 1): S61-5.
24. Schilling, J.D., Martin, S.M., Hung, C.S., Lorenz, R.G., Hultgren, S.J. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc Natl Acad Sci USA 2003, 100: 4203-8.
25. Wang, X., Moser, C., Louboutin, J.P. et al. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol 2002, 168: 810-15.
26. Bernheiden, M., Heinrich, J.M., Minigo, J. et al. LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection. J Endotox Res 2001, 7: 447-50.
27. Wang, M.J., Jeng, K.C.G., Ping, L.I. Exogenous cytokine modulation or neutralization of interleukin-10 enhance survival in lipopolysaccharide- hyporesponsive C3H/HeJ mice with Klebsiella infection. Immunology 1999, 98: 90-7.
28. Netea, M.G., de Graaf, C., Vonk, A., Verschueren, I., Van der Meer, J.W.M., Kullberg, B.J. The role of Toll-like receptors in the defense against disseminated candidiasis. J Infect Dis 2002, 185: 1483-9.
29. Tada, H., Nemoto, E., Shimauki, H. et al. Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol Immunol 2002, 46: 503-12.
30. Netea, M.G., Van der Graaf, C., Van der Meer, J.W.M., Kullberg, B.J. The role of Toll-like receptors in host defense: Bringing specificity to the innate immune response. J Leuk Biol 2004, 75: 749-55.
31. Serbina, V., Kuziel, R., Flavell, R., Akira, S., Rollins, B., Pamer, E.G. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 2003, 19: 891-901.
32. Weiss, D.S., Raupach, B., Takeda, K., Akira, S., Zychlinsky, A. Toll-like receptors are temporally involved in host defense. J Immunol 2004, 172: 4463-9.
33. Hirschfeld, M., Weis, J.J. Toshchakov, V. et al. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 2001, 69: 1477-82.
34. Re, F., Strominger, J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001, 276: 37692-9.
35. Agrawal, S., Agrawal, A., Doughty, B. et al. Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen- activated protein kinase and c-Fos. J Immunol 2003, 171: 4984-9.
36. Dillon, S., Agrawal, A., Van Dycke, T. et al. Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 2004, 172: 4733-43.
37. Redecke, V., Hacker, H., Datta, S.K. et al. Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004, 172: 2739-43.
38. Sing, A., Rost, D., Tvardovskaia, N. et al. Yersinia V-antigen exploits Toll-like receptor 2 and CD14 for interleukin-10-mediated immunosuppression. J Exp Med 2002, 196: 1017-24.
39. Netea, M.G., Sutmuller, R., Hermann, C. et al. Toll-like receptor 2 inhibits cellular responses against Candida albicans through pathways mediated by IL-10 and CD4+CD25+ regulatory T cells. J Immunol 2004, 172: 3712-18.
40. Villamon, E., Gozalbo, D., Roig, P., O'Connor, J.E., Fradelizi, D., Gil, M.L. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect 2004, 6: 1-7.
41. Alvarez, G.R., Zwilling, B.S., Lafuse, W.P. Mycobacterium avium inhibition of IFN-gamma signaling in mouse macrophages: Toll-like receptor 2 stimulation increases expression of dominant-negative STAT1beta by mRNA stabilization. J Immunol 2003, 171: 6766-73.
42. Gehring, A.J., Rojas, R.E., Canaday, D.H., Lakey, H.L., Harding, C.V., Boom, W. H. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and FcgR1 on human macrophages through Toll-like receptor 2. Infect Immun 2003, 71: 4487-97.
43. Asai, Y., Hashimoto, M., Ogawa, T. Treponemal glycoconjugate inhibits Toll-like receptor ligand-induced cell activation by blocking LPS-binding protein and CD14 functions. Eur J Immunol 2003, 33: 3196-204.
44. Hashimoto, M., Asai, Y., Ogawa, T. Treponemal phospholipids inhibit innate immune responses by pathogen-associated molecular patterns. J Biol Chem 2003, 278: 44205-13.
45. Harte, M.T., Haga, I.R., Maloney, G. et al. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med 2003, 197: 343-52.
46. DiPerna, G., Stack, J., Bowie, A.G. et al. Poxvirus protein N1L targets the IkappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem 2004, 279(35): 36570-8.
47. Netea, M.G., Warris, A., Van der Meer, J.W.M. et al. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis 2003, 188(2): 320-6.